Mathijs C Bunck (Mark M Smits)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 10

Top Venues

Diabetes care

Diabetes

Diabetes, obesity & metabolism

Diabetes/metabolism research and reviews

VU medisch centrum

VU University Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VU medisch centrum

Netherlands

MD PhD :: Internal Medicine / Diabetes Center

Education History

VU University Medical Center Jan 01 2012 - Nov 15 2017

Netherlands

PHD :: Medicine

Publications

Mathijs C Bunck, Katrine D Galsgaard, Sara Lind Jepsen, Nicolai J Wewer Albrechtsen, Bolette Hartmann, Jens Juul Holst
In vivo inhibition of dipeptidyl peptidase 4 allows measurement of GLP-1 secretion in mice. Diabetes (2024)
Mathijs C Bunck, Katrine D Galsgaard, Sara Lind Jepsen, Nicolai J Wewer Albrechtsen, Bolette Hartmann, Jens Juul Holst
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice. Diabetes 73 (5) (2024)
Mathijs C Bunck, Jens J Holst
Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: Could this work and how? Diabetes/metabolism research and reviews (2023)
Mathijs C Bunck, Daniël H van Raalte
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390. Diabetes care 46 (5) (2023)
Mathijs C Bunck, Daniël H van Raalte
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390. Diabetes care 46 (5) (2023)
Marcel H A Muskiet, Lennart Tonneijck, Mathijs C Bunck, Mark H H Kramer, D Margriet Ouwens, Bolette Hartmann, Jens J Holst, A H Jan Danser, Jaap A Joles, Daniël H van Raalte
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial. Diabetes, obesity & metabolism 24 (1) (2021)
Marcel H A Muskiet, Lennart Tonneijck, Mathijs C Bunck, D Margriet Ouwens, Jens Juul Holst, Alexander H J Danser, Daniël H van Raalte
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. Diabetes care 43 (11) (2020)
Jordan Kraaijenhof, Marcel H A Muskiet, Lennart Tonneijck, D Margriet Ouwens, Mark H H Kramer, Daniël H van Raalte, Mathijs C Bunck
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial. Diabetes, obesity & metabolism 22 (10) (2020)
Mathijs C Bunck, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer, Djuna L Cahen
GLP-1 based therapies: clinical implications for gastroenterologists. Gut 65 (4) (2016)
Mathijs C Bunck, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer, Indra C Pieters-van den Bos, Karuna E W Vendrik, Trynke Hoekstra, Marco J Bruno, Michaela Diamant, Daniël H van Raalte, Djuna L Cahen
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial. Diabetes care 40 (3) (2016)
Mathijs C Bunck, Marcel H A Muskiet, Lennart Tonneijck, Daniël H van Raalte
Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098. Diabetes care 38 (7) (2015)
Mathijs C Bunck, Lennart Tonneijck, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, Indra C Pieters, Djuna L Cahen, Michaela Diamant, Daniël H van Raalte
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes. BMJ open 5 (11) (2015)
Mark M Smits, Mathijs C Bunck, Michaela Diamant, Anja Corner, Bjorn Eliasson, Robert J Heine, Ulf Smith, Hannele Yki-Järvinen, Daniël H van Raalte
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels. Diabetes care 39 (3) (2015)

Mathijs C Bunck.css-eqlu8i{font-size:small;padding-left:4px;} (Mark M Smits)

Publication Activity (10 Years)

Top Topics

Top Venues

Mathijs C Bunck (Mark M Smits)